Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Kalaris Therapeutics, Inc., formerly AlloVir, Inc., is a clinical-stage biopharmaceutical company engaged in the development and commercialization of treatments for prevalent retinal diseases. The Company is focused on the development of TH103, a differentiated anti-vascular endothelial growth factor (VEGF) investigational therapy. TH103 is a fully humanized, recombinant fusion protein that acts against VEGF as a decoy receptor and has been specifically engineered for potentially improved VEGF inhibition and longer retention in the retina. TH103 is being evaluated in an ongoing, Phase I clinical trial for the treatment of neovascular age-related macular degeneration (nAMD), with plans to develop TH103 for additional neovascular and exudative diseases of the retina such as diabetic macular edema (DME), and retinal vein occlusion (RVO).
Find out what a historical investment in Kalaris Therapeutics Inc would be worth today using our KLRS stock calculator.
Buying KLRS shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Kalaris Therapeutics Inc in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in KLRS
What is the ticker symbol of Kalaris Therapeutics Inc?
The ticker symbol for Kalaris Therapeutics Inc is KLRS.
How much is one share of KLRS?
One share of KLRS is valued at $1.35 as of 20 November 2026.
What is the market capitalisation of Kalaris Therapeutics Inc KLRS?
As of 20 November 2026 Kalaris Therapeutics Inc has a market cap of $32.61M.
What is the 52-week high for Kalaris Therapeutics Inc stock?
The Kalaris Therapeutics Inc 52-week high stock price is $11.88.
What is the 52-week low for Kalaris Therapeutics Inc stock?
The Kalaris Therapeutics Inc 52-week low stock price is $1.33.
Can I buy KLRS shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy KLRS shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in KLRS on Stake
Buy KLRS from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of KLRS from only US$10 with fractional shares